2026-04-28T22:02:24Zhttps://uvadoc.uva.es/oai/request

oai:uvadoc.uva.es:10324/539632022-07-18T09:33:03Zcom_10324_22821com_10324_954com_10324_894col_10324_22822

Ribeiro Paulini, Marina Camal Ruggieri, Iván Nadir Ramallo, Melina Alonso Rodrigo, Matilde Rodríguez Cabello, José Carlos Esbrit, Pedro Mardegan Issa, João Paulo Feldman, Sara 2022-07-14T08:39:52Z 2022-07-14T08:39:52Z 2021 Biomolecules, 2021, vol. 12, n. 1, p. 3 2218-273X https://uvadoc.uva.es/handle/10324/53963 10.3390/biom12010003 3 1 Biomolecules 12 2218-273X The increase in fracture rates and/or problems associated with missing bones due to accidents or various pathologies generates socio-health problems with a very high impact. Tissue engineering aims to offer some kind of strategy to promote the repair of damaged tissue or its restoration as close as possible to the original tissue. Among the alternatives proposed by this specialty, the development of scaffolds obtained from recombinant proteins is of special importance. Furthermore, science and technology have advanced to obtain recombinant chimera’s proteins. This review aims to offer a synthetic description of the latest and most outstanding advances made with these types of scaffolds, particularly emphasizing the main recombinant proteins that can be used to construct scaffolds in their own right, i.e., not only to impregnate them, but also to make scaffolds from their complex structure, with the purpose of being considered in bone regenerative medicine in the near future. eng info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/4.0/ © 2021 The Author(s) Atribución 4.0 Internacional Recombinant proteins-based strategies in bone tissue engineering info:eu-repo/semantics/article